We found an excellent outcome for patients with ETV6/RUNX1-positive leukemia relapses that occurred more than 36 months after diagnosis. The duration of first complete remission may, therefore, be a guide to define the treatment strategy for patients with relapsed ETV6/RUNX1- positive leukemia
The most common cause of treatment failure in childhood acute lymphoblastic leukemia (ALL) remains r...
The most common cause of treatment failure in childhood acute lymphoblastic leukemia (ALL) remains r...
International audienceBackground: The treatment of children with T‐cell lymphoblastic lymphoma (T‐LB...
The online version of this article has a Supplementary Appendix. Background The prognosis of patient...
International audiencePurpose. The prognosis of relapses of ETV6/RUNX1-positive acute lymphoblastic ...
The prognostic impact of t(12;21)(p13;q22) [ETV6/RUNX1 fusion] in paediatric acute lymphoblastic leu...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Abstract Background In childhood B-precursor acute lymphoblastic leukemia (B-ALL), the ETV6/RUNX1 fu...
Background. We report on the treatment of children and adolescents with acute lymphoblastic leukemia...
Item does not contain fulltextBACKGROUND: We report on the treatment of children and adolescents wit...
This study was undertaken in order to compare the interphase and metaphase cytogenetics of 28 patien...
Background. We report on the treatment of children and adolescents with acute lymphoblastic leukemia...
Few data are available on the long-term outcome of children who present with a very late relapse of ...
The most common cause of treatment failure in childhood acute lymphoblastic leukemia (ALL) remains r...
The most common cause of treatment failure in childhood acute lymphoblastic leukemia (ALL) remains r...
International audienceBackground: The treatment of children with T‐cell lymphoblastic lymphoma (T‐LB...
The online version of this article has a Supplementary Appendix. Background The prognosis of patient...
International audiencePurpose. The prognosis of relapses of ETV6/RUNX1-positive acute lymphoblastic ...
The prognostic impact of t(12;21)(p13;q22) [ETV6/RUNX1 fusion] in paediatric acute lymphoblastic leu...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Abstract Background In childhood B-precursor acute lymphoblastic leukemia (B-ALL), the ETV6/RUNX1 fu...
Background. We report on the treatment of children and adolescents with acute lymphoblastic leukemia...
Item does not contain fulltextBACKGROUND: We report on the treatment of children and adolescents wit...
This study was undertaken in order to compare the interphase and metaphase cytogenetics of 28 patien...
Background. We report on the treatment of children and adolescents with acute lymphoblastic leukemia...
Few data are available on the long-term outcome of children who present with a very late relapse of ...
The most common cause of treatment failure in childhood acute lymphoblastic leukemia (ALL) remains r...
The most common cause of treatment failure in childhood acute lymphoblastic leukemia (ALL) remains r...
International audienceBackground: The treatment of children with T‐cell lymphoblastic lymphoma (T‐LB...